LONDON (MedPage Today) -- A drug combination with striking efficacy in relatively healthy hepatitis C patients had similar outcomes in patients with compensated cirrhosis, a researcher said. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment